Using Near-Infrared Light to Better Understand Peripheral Artery Disease

Part of paid clinical trials in Arlington, Texas.

Sponsor
The University of Texas at Arlington
Study ID
NCT07313410
Status
Recruiting
Apply to this trial

Conditions

  • Peripheral Artery Disease (PAD)

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

The goal of this study is to better understand how blood flows and how oxygen is utilized in the lower limbs of people who suffer from peripheral artery disease. This study will also assess how these factors affect treatment outcomes. Specific aims include: Aim 1: Utilize BB-NIR-DCS to differentiate PAD patients experiencing primary oxygen delivery limitations from those suffering from mitochondrial dysfunction. Aim 2: Test the efficacy of BB-NIR-DCS at predicting individual responses to vascular intervention.

Key Dates

Start date
Nov 1, 2025
Status verified
Dec 2025
Primary completion
Dec 31, 2028
Completion
Dec 31, 2028

Study Design

Enrollment
120 participants (estimated)

Arms

  • Arm: Healthy Controls
    Individuals without PAD
  • Arm: Cases with PAD
    Individuals with PAD

Primary Outcome Measure

Perceived Quality of life [ Time Frame: Baseline and up to 26 weeks ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
University of Texas ArlingtonArlingtonTexas76019
Rajvi Shah, MPH
[email protected]
2147557343
Michael Nelson, PhD (PRINCIPAL_INVESTIGATOR)
University of Texas at ArlingtonArlingtonTexas76010
Rajvi Shah
2147557

Find similar trials in Arlington, TX

By research site
University of Texas Arlington· Arlington, TXUniversity of Texas at Arlington· Arlington, TX

Related Studies